Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

J.P. Morgan Sticks to Its Hold Rating for Novo Nordisk (0QIU)

Tipranks - Tipranks - Tue Apr 21, 8:10AM CDT

J.P. Morgan analyst Richard Vosser maintained a Hold rating on Novo Nordisk today and set a price target of DKK250.00.

Claim 30% Off TipRanks

According to TipRanks, Vosser is a 3-star analyst with an average return of 1.5% and a 48.13% success rate.

In a report released today, Jefferies also maintained a Hold rating on the stock with a DKK270.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Based on Novo Nordisk’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of DKK79.14 billion and a net profit of DKK26.89 billion. In comparison, last year the company earned a revenue of DKK85.68 billion and had a net profit of DKK28.23 billion

Based on the recent corporate insider activity of 22 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of 0QIU in relation to earlier this year.

Read More on GB:0QIU:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).